DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	TNFRSF10B; TNFRSF13B; LILRA1; F2; PRL; IFNB1; IFNG; IL2RA; CD3D; GP1BA; INHBA; CD3G; SAG; CCL2; NPR1; CXCR1; LAMA1; VIPR2; GLP1R; IFNAR2; CXCR3; CCR5; COL4A3; ADGRE1; ADGRE4P; LILRB2; CD101; ADGRE3; CLEC1B; CLEC4A; TRBV24-1; TRBV6-4; TRBV19; TRBV6-6; TRBV5-1; CD80; TRBV6-1; TRBV7-1; TRBV27; TRBV6-8; TRBV17; TRBV5-5; TRBV3-1; TRBV2; TRBV13; TRBV28; TRBV6-2; TRBV11-1; TRBV25-1; TRBV7-2; TRBV4-1; TRBV11-3; TRBV7-6; TRBV29-1; TRBV10-1; TRBV7-7; TRBV14; TRBV15; TRBV5-7; TRBV30; TRBV10-2; TRBV6-7; TRBV4-2; TRBV20-1; TRBV7-4; TRBV12-5; TRBV6-5; TRBV12-4; TRBV5-6; TRBV16; TRBV23-1; TRBV5-4; TRBV9; TRBV12-3; TRBV18; TRBV7-9; TRBV11-2; PDCD1LG2; TRBV10-3;	GO:0007166~cell surface receptor signaling pathway	79	268	29.4776119402985	0	0	0	0	0	0	0
up	MS4A1; CD19; CTLA4; MNDA; NCKAP1L; IGHV4-34; IGHV3-11; IGHV2-5; IGLL5; IGLC3; IGHV3-35; IGHV3-13; TRBC2; IGHV5-51; CD79B; IGHV1-46; IGHV6-1; IGHV3-38; IGHV1-18; IGHV3-16; IGHV1-24; TRBC1; TRDC; IGHD; IGLC2; IGHV4-31; IGHV3-49; IGKC;	GO:0050853~B cell receptor signaling pathway	28	125	22.4	0.00010558156227591	0.0508148976153648	0.355070793933898	0.355704283307553	0.35475404924707	0.355070793933898	0.44207615920872
down	SRPX2; EGFR; CSTA; ANXA1; KRT18; ANXA2; CDH1; JUP; CRISP2; CD24; CD34; S100A11; CDH5; ITGA8; RAB10; CX3CL1; DSG1; FOXF1; DLG1; TRIM29; CNN3; CDSN; STXBP6; CRNN; BAIAP2L1; CTNNA3; BAIAP2; CDH10; LRRC1; DLG3; CDH6; CTNND1; CDH17; DSG3; CDH12; PKP3; DSC3; DSC2; CDH19; IGSF5; DLG2; PKP1; DSP;	GO:0098609~cell-cell adhesion	43	152	28.2894736842105	0.00015370071157327	0.0580412312078595	0.926354188652153	0.928659699325753	0.792173467448681	0.926354188652153	0.538842530984834
down	PSMD11; PSMD12; PSMD14; SLC16A6; ABCC9; ERLIN1; GJB3; PSMD10; ABCA8; SLCO2B1; GJB6; APOA1; SLC25A5; EIF2S1; GJB1; CFTR; EIF2S2; SLC6A2; AZGP1; PSMA1; PSMA3; PSMA4; PSMA5; PSMB6; PSMB5; ABCD3; GJB2; MIP; SLC6A1; PSMC2; SLC6A11; PSMD8; SLC18A1; AQP5; AQP4; PSMC6; OCA2; SLC10A2; SLC10A6; SLC44A4; PDZD11; SLC22A10; SLC22A25; SLC16A9; SLCO6A1; ABCA12; SLC51B; SLC47A2; SPNS2; SLC44A3; SLC25A41; MFSD2A; SLC44A5; SLC22A8; SLC25A43; SLCO2A1; SLCO4A1; PSMB7; PSMD1; SLC25A21; SLCO5A1; GJB4; SLCO1C1; STEAP1; ABCG2; GJA3; SLC19A2; SLC19A3;	GO:0055085~transmembrane transport	68	285	23.859649122807	0.00021380577216856	0.0759890867907327	1	1	0.888362983360378	0.999999999998597	0.70546663124541
up	TLR9; IGHV3-16; IGHV3-38; IGHV3-49; IGLC3; IGHD; IGHV3-13; TRBC1; IGHV1-18; IGLL5; IGHV1-24; IGHV3-11; TRBC2; IGLC2; IGHV1-46; IGHV4-31; IGHV5-51; IGHV6-1; IGHV4-34; TRDC; IGKC; IGHV3-35; IGHV2-5;	GO:0050871~positive regulation of B cell activation	23	98	23.469387755102	0.0002358457074667	0.0865341602143427	0.792913268503074	0.794564188455341	0.792205731380674	0.792913268503074	0.752824289393858
up	FCN1; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-40; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGHV1-46; IGHV3-11; IGHV3-13; IGHV2-5; IGKC; IGLV7-43; IGKV1-16; IGKV3-11; IGKV4-1; IGHV4-34; IGLC2; IGLC3;	GO:0006956~complement activation	22	92	23.9130434782609	0.0002549733624112	0.0865341602143427	0.856965471064056	0.859005257963346	0.856455524339234	0.856965471064056	0.752824289393858
up	F2; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-40; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGHV1-46; IGHV3-11; IGHV3-13; IGHV2-5; IGKC; C4BPA; IGLV7-43; IGKV1-16; IGKV3-11; CFI; IGKV4-1; IGHV4-34; IGLC2; IGLC3; CD19;	GO:0030449~regulation of complement activation	25	113	22.1238938053097	0.00028253955546386	0.0865341602143427	0.949050366803131	0.95187576235777	0.914298001481076	0.949050366803131	0.752824289393858
down	S100A8; EDN1; S100A9; SAA1; EDN3; DPEP1; EDN2; CXADR; S100A12; CCL1; CXCL9; CXCL1; CCL22; CX3CL1; CCL21; CCL13; CCL16; CCL14; CCL17; CXCL10; CCL11; CCL18; CCL19; CXCL13; CXCL11; CCL20;	GO:0030593~neutrophil chemotaxis	26	76	34.2105263157895	0.00028564996800262	0.0899946380091295	1	1	0.961182085990289	0.999999999998597	0.835491210485155
down	AKR1B10; LRAT; ADH1B; APOA1; APOE; APOC3; APOB; APOA4; LPL; RBP1; RBP3; SDC1; SDC4; ADH7; AKR1C3; AKR1C1; GPIHBP1; RDH10; RDH12; RARRES2; STRA6; BCO2; BCO1;	GO:0001523~retinoid metabolic process	23	63	36.5079365079365	0.00029613195461597	0.0899946380091295	1	1	0.96919753968132	0.999999999998597	0.835491210485155
down	CCL21; FGF10; RAMP3; EGFR; HRAS; APOE; HMGCR; BMP2; MIF; PLA2G2A; PDGFRA; ADCYAP1; FGFR3; FSHR; MAPK3; CALCR; S100A7; ADRA1A; FLT4; KDR; CHRNA7; PLA2G5; THPO; CASR; GATA4; CX3CL1; TEK; GPNMB; P2RY6; ANGPT1; SYT14P1; TNFAIP8L3; FFAR4; NPNT; SLC30A10; CCL19; GAREM1; TRPV4; FGF20; NOX4; TREM2; NDRG4; CCL11; CCL1; CCL17; HMGB1P1; CCL22; CCL20; CCL14; CCL13; ROR1; CCL18; CCL16;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	53	209	25.3588516746411	0.0002978968487558	0.0899946380091295	1	1	0.970028510980187	0.999999999998597	0.835491210485155
down	UGT1A9; UGT1A1; UGT1A3; UGT2B28; UGT1A7; UGT1A8; UGT1A10; UGT1A6;	GO:0052697~xenobiotic glucuronidation	8	9	88.8888888888889	0.00052086253274819	0.131127142619357	1	1	0.999999999998597	0.999999999998597	1
up	IGHV3-11; IGLL5; TRDC; IGHV1-46; IGHV3-16; TRBC2; IGHV3-35; IGHV1-18; IGHV3-49; IGLC3; IGHV3-13; IGHV3-38; IGHV2-5; IGHD; TRBC1; IGHV5-51; IGLC2; IGKC; IGHV6-1; IGHV4-31; IGHV1-24; IGHV4-34;	GO:0006910~phagocytosis, recognition	22	99	22.2222222222222	0.00060310540357932	0.169321842054897	1	1	1	1	1
down	UGT1A9; UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A6; UGT1A10;	GO:0052696~flavonoid glucuronidation	7	7	100	0.00075092114517416	0.174502521505473	1	1	0.999999999998597	0.999999999998597	1
down	CLCA1; CLDN4; GABRD; CLIC3; CFTR; GABRB3; CASR; SLC1A3; SLC1A1; GABRA2; GABRB2; CLCN3; CLCNKB; CLDN17; FXYD3; CLCA4; ANO4; SLC26A9; CLIC6; ANO3; GABRQ; CLCA2; CLCA3P; GABRA3; GABRA4; SLC12A8; GABRG3; GABRA5; GABRE;	GO:1902476~chloride transmembrane transport	29	97	29.8969072164948	0.00082258974321392	0.184077304759204	1	1	0.999999999998597	0.999999999998597	1
down	CXCL11; CXCL10; XCR1; CXCL12; CX3CL1; FOXC1; GPR17; ACKR1; CCL16; CCL22; CCL21; CCL11; CCL13; CXCL9; CCL1; CCL14; TFF2; CXCL1; CXCL13; CCL20; CCL17; CCL18; CCL19;	GO:0070098~chemokine-mediated signaling pathway	23	70	32.8571428571429	0.00097605774370113	0.210619317408651	1	1	0.999999999998597	0.999999999998597	1
up	TNFRSF10B; F2; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-40; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGHV1-46; IGHV3-11; IGHV3-13; IGHV2-5; IGKC; GYPA; FN1; IGLV7-43; IGKV1-16; IGKV3-11; GYPB; IGKV4-1; IGHV4-34; DBH; CD48; IGLC2; IGLC3; CD44; ITGA3; CEACAM8; L1CAM; SIRPG; CD84;	GO:0050900~leukocyte migration	34	193	17.6165803108808	0.00105028506453231	0.272185414031488	1	1	1	1	1
down	CFTR; AQP1; SCNN1A; SCNN1B; SCNN1G; AQP4; TRPV4;	GO:0050891~multicellular organismal water homeostasis	7	8	87.5	0.00125562346213481	0.252882565273952	1	1	0.999999999998597	0.999999999998597	1
up	AIF1; IGLC2; IGHV1-24; IGHV2-5; TRDC; TRBC2; IGHV3-11; IGHV3-16; IGHV3-49; IGHV1-46; IGHV6-1; IGHV3-13; IGHV3-35; IGKC; IGHV4-34; IGLC3; IGHV5-51; IGHV1-18; IGHV3-38; IGHD; IGLL5; TRBC1; IGHV4-31;	GO:0006911~phagocytosis, engulfment	23	115	20	0.00157220251833479	0.378339306019278	1	1	1	1	1
down	PSMD11; PSMD12; PSMD14; PSMD10; HRAS; MUC1; PSMA1; PSMA3; PSMA4; PSMA5; PSMB6; PSMB5; PSMC2; PSMD8; PSMC6; MUC5AC; MUC3A; MUC2; MUC21; MUC17; CLEC10A; MUC20; MUC15; MUC16; MUCL1; PSMB7; PSMD1; MUC13; MUC5B; CD209; FBXW11;	GO:0002223~stimulatory C-type lectin receptor signaling pathway	31	112	27.6785714285714	0.00157921758870216	0.289140383967833	1	1	0.999999999998597	0.999999999998597	1
down	CXCL11; RAMP2; RAMP3; VIP; CXCL10; ADRA2A; ADCYAP1; DRD1; DRD5; LHCGR; CALCR; MC5R; GPR4; GCGR; CXCL9; ADCY2; ADGRF1; GPR26; GPR78; ADGRG6; PTGER3; LGR4; RXFP1; PTGFR; PTGER1; FSHR; ADGRL4; ADGRL3; ADGRL2;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	29	103	28.1553398058252	0.00177111148318854	0.305744445183575	1	1	0.999999999998597	0.999999999998597	1
down	RAMP2; RAMP3; NFASC; TSPAN15; ATP1B1; ANXA2; RAP2A; CDH1; JUP; EZR; EPHA2; DPP6; RAB13; ATP1B3; EMP2; CAV3; S100A10; RAB10; RAB11A; ANK2; DLG1; MAP7; TMED2; WDR72; ABCA12; DPP10; MRAP; KCNB2; NKD2; MRAP2; CRB3; FAM126A; SPTBN4; EPB41L3; PKP3; RAB40AL; RAB3C;	GO:0072659~protein localization to plasma membrane	37	144	25.6944444444444	0.00183582917956671	0.308113330637279	1	1	0.999999999998597	0.999999999998597	1
down	APOA1; APOE; APOC3; APOB; APOA4; LPL; GPIHBP1;	GO:0034371~chylomicron remodeling	7	9	77.7777777777778	0.00199122743498326	0.318332640569321	1	1	0.999999999998597	0.999999999998597	1
up	TRGV2; TRGV5; TRGV8; TRGV4; TRDV1; TRDV2; TRDV3; IRGM; LILRA5; CD300LB; HMGB3; TYROBP; LY86; NCR2; TRGV3; C4BPA; APP; CFI; NLRP2B; RNASE3; DEFA4; KIR2DS4; NLRP6; LILRA4; SIGLEC14; SLAMF1; PRKD1; CD300E; CLEC6A; TREML4; NLRP9; LILRA2; IL27; CLEC4C; RNASE6; SIGLEC10; PGLYRP2; CD180; TRGV9; TLR9; TLR8; TLR7; TRIM10; CD84; CLEC4A; MFHAS1; TRDC; IGHV3-16; IGHV3-35; TRBC1; TRBC2; IGLC3; IGHV3-13; IGHV3-49; IFNL1; IGHV6-1; IGHV5-51; IGHV3-38; IGHV1-18; IGHV1-46; IGLL5; IGLC2; IGHV1-24; IGHV4-31; BPI; IGHV3-11; IGHV4-34; IGKC; IGHV2-5; IGHD;	GO:0045087~innate immune response	70	505	13.8613861386139	0.00203329727813739	0.456678568669658	1	1	1	1	1
down	PSMD11; PSMD12; PSMD14; NRG2; EREG; SPTBN2; FGF10; GFRA3; PSMD10; RASAL1; EGFR; HRAS; TGFA; ERBB2; FGF1; PDGFRA; FGF7; ERBB3; FGFR3; PSMA1; PSMA3; PSMA4; MAPK3; PSMA5; PSMB6; PSMB5; PEBP1; MAPK4; BTC; PSMC2; GDNF; PSMD8; YWHAE; PSMC6; TEK; DLG1; IL18; ANGPT1; DLG2; MAPK6; DUSP5; EPGN; KLB; IL17RD; DLG3; PBK; RANBP9; HBEGF; PSMB7; PSMD1; NRTN; DUSP9; GFRA4; SPTBN4; FGF20; LAMTOR3; RASAL2;	GO:0000165~MAPK cascade	57	254	22.4409448818898	0.00217271724563273	0.323570166759397	1	1	0.999999999998597	0.999999999998597	1
down	MT1X; MT1E; MT1B; MT1A; MT4; MT1H; MT1M; MT1DP; MT1G;	GO:0010273~detoxification of copper ion	9	16	56.25	0.00237383909857092	0.331758327824517	1	1	0.999999999998597	0.999999999998597	1
down	DEFB4A; KRT6A; HRG; S100A9; S100A7; H2BFS; DEFB1; S100A12; DEFA5; PGLYRP4; PGLYRP3; CCL13; RNASE7; CXCL9; CXCL1; DEFA6; CXCL10; CXCL11; CXCL13; REG1A;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	20	62	32.258064516129	0.00241466440933713	0.331758327824517	1	1	0.999999999998597	0.999999999998597	1
down	NTN3; SPTBN2; PLA2G10; GFRA3; SLIT2; NFASC; LGI1; GLI2; EZR; BMP7; MAPK3; GDNF; WNT5A; CXCL12; ETV1; EPHB3; EPHA5; WNT3A; VLDLR; SEMA3F; GRB7; CNTN4; DOK4; RANBP9; NRTN; BOC; GFRA4; SPTBN4; ROBO2; B3GNT2; VSTM2L; EFNA3; EFNA2; EPHA3; EFNA5; IGSF9; EFNB2; EPHA10; UNC5B; EPHA2; ROBO4; EFNA1; LRTM1; EPHA1; EPHA6; UNC5C; PALLD; UNC5D;	GO:0007411~axon guidance	48	206	23.3009708737864	0.00247089122014288	0.331758327824517	1	1	0.999999999998597	0.999999999998597	1
up	ARPC1B; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-40; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGHV1-46; IGHV3-11; IGHV3-13; IGHV2-5; IGKC; IGLV7-43; IGKV1-16; IGKV3-11; IGKV4-1; IGHV4-34; CD3G; IGLC2; IGLC3; FCGR2A; NCKAP1L;	GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis	25	135	18.5185185185185	0.00253564595305278	0.533911950989676	1	1	1	1	1
down	EREG; FGF10; EGFR; KRT6A; ERBB2; S100A8; SERPINB2; FGF1; REG1A; DCN; PDGFRA; SDC1; ERBB3; DRD5; SDC4; WNT5A; GRHL3; EPB41L4B; CCM2L; SPRR3; DSP; EVPL; EVPLL; PPL;	GO:0042060~wound healing	24	82	29.2682926829268	0.00277700925379654	0.350835205432591	1	1	0.999999999998597	0.999999999998597	1
down	PTGES; FGF10; GJB6; CLDN1; REN; PENK; SLPI; APOB; CYP1A1; S100A8; EDN1; DCN; MGST1; SCGB1A1; IDO1; HPGD; SELE; GJA1; UGT1A1; MAOB; GJB2; IL12A; S100A7; PTGER1; PCK1; PTGFR; BDKRB1; MGST2; TRIM6; S100A14; GNG12; TNFRSF11A; GGT5; NOS1; NOS2;	GO:0032496~response to lipopolysaccharide	35	138	25.3623188405797	0.00286143877187806	0.350835205432591	1	1	0.999999999998597	0.999999999998597	1
down	CLCA1; KCNK3; GRID2; ATP6V1G1; ATP1B1; S100A6; GJA1; ATP4A; CHRNA7; SCNN1A; GRIA1; ATP1A2; SCNN1B; SCNN1G; CLCNKB; ATP1B3; GRIK2; GRIK3; FXYD3; CLCA4; GRIK4; ANO4; ATP13A4; PDZD11; TMC5; GJD3; ATP6V1C2; ANO3; ATP6V0A4; SGK2; ASIC5; UNC79; CLCA2; ATP6V1D; CLCA3P; GABRA3; GABRA5; GABRB3; GABRG3; GABRA2; GABRD; GABRQ; GABRE; GABRA4; HTR3B; HTR3A; HTR3E; GABRB2;	GO:0034220~ion transmembrane transport	48	208	23.0769230769231	0.00290330358683044	0.350835205432591	1	1	0.999999999998597	0.999999999998597	1
down	C3orf70; SRRM4; FZD9; NRG2; DCLK1; MSI1; TIMM8A; KALRN; LGI1; APOB; GJB1; CHRM2; CXCL1; NTF3; PTN; ACHE; CBLN1; EDNRB; CNTFR; GDNF; NBL1; EFNA5; DLX5; FGF12; VLDLR; PCDH1; SEMA5A; SIM2; HES1; CNTN4; PLPPR1; ST8SIA2; RAPGEF5; NELL1; FGF14; ATOH8; LINC01587; NRTN; CHRDL1; SDCBP2; NRN1; RAPGEFL1; INTU; PCDHA7; PCDHA6; PCDHA4; GDA; UTP11; MAB21L2; PCDHB4; PCDHB11; PCDHA8; PCDHA5; PCDHA3; PCDHA11; PCDHA10; PCDHAC2; ERBB3; GFRA3; RBFOX1; TYRO3; ROR1; GFRA4;	GO:0007399~nervous system development	63	294	21.4285714285714	0.00334190125152323	0.395917007092222	1	1	0.999999999998597	0.999999999998597	1
down	GMDS; KRT19; BMP2; GOT1; AGXT; HOXD3; HNF1B; CDH6; FOXA1; MESP2; CNTN1; FOXC1; TBX2; HES1; NR0B2; HES5; RIPPLY2; NRARP; PERP; NR1H4; MESP1; CHAC1; GRIP2; WDR12; DLL4; TMEM100; HEY2; NOTCH3; SORBS2;	GO:0007219~Notch signaling pathway	29	109	26.605504587156	0.00354050084886326	0.401923281550499	1	1	0.999999999998597	0.999999999998597	1
down	AKR1C3; ALDH1A3; AKR1C1; RDH10; SDR16C5; RDH13; BCO2; BCO1;	GO:0042574~retinal metabolic process	8	14	57.1428571428571	0.00383839993941648	0.420869507432154	1	1	0.999999999998597	0.999999999998597	1
down	COL6A5; ISLR; PDZD2; RS1; EFS; EDIL3; CNTN5; ITGBL1; ATP1B1; HAPLN1; CEACAM1; ACHE; AZGP1; EPHA2; EPHA3; COL15A1; CXCL12; CCL11; EFNB2; EMP2; SLURP1; AFDN; CDH6; LGALS4; RND3; CLDN10; CX3CL1; DSC2; ROM1; TYRO3; DPT; LGALS3BP; CNTN1; CDH17; SEMA5A; PKP1; LY6D; MYBPC2; HES1; HABP2; DSC3; OPCML; CDSN; LAMA4; COL28A1; FLG2; HES5; GRHL2; MPZL3; AMTN; EGFL6; MUC16; MAGI1; AMELX; CGREF1; BOC; STAB1; CTNNAL1; CLCA2; PCDHB8; PCDH17; PCDHA13; PCDHA3; PCDH1; CDH16; PCDHA7; PCDHGA2; PCDHA10; PCDHAC2; PCDHA11; SIGLEC6; PCDH11Y; PCDHA5; PCDHB5; PCDHA9; PCDHGA1; PCDHB10; PCDHGB4; PCDHB11; PCDH18; PCDHGA10; PCDHA4; PCDH11X; PARD3; PCDHGC4; GPNMB; PCDHB4; PCDHA8; PCDHA12; PCDHA6;	GO:0007155~cell adhesion	90	454	19.8237885462555	0.0039008097345582	0.420869507432154	1	1	0.999999999998597	0.999999999998597	1
down	PLA2G10; PLA2G2A; PLA2G5; PLA2G4A; PLA2G4F; PLA2G4D; SERAC1; PLA2G2F; PLA2G3;	GO:0036148~phosphatidylglycerol acyl-chain remodeling	9	18	50	0.00431212243148804	0.449204202259496	1	1	0.999999999998597	0.999999999998597	1
down	LGI1; SLC1A3; GRIK2; KISS1; RIMS1; NMU; CLSTN2; RIMS2; RIMS4;	GO:0050806~positive regulation of synaptic transmission	9	18	50	0.00431212243148804	0.449204202259496	1	1	0.999999999998597	0.999999999998597	1
up	OR2A1; OR2A42; OR5B21; OR1F1; OR2H2; OR4E1; OR2T7; OR3A1; OR3A4P; OR3A3; OR4D2; OR4D1; OR2B11; OR2G6; OR2T2; OR2W3; OR2L13; OR2C3; OR2L5; OR2AK2; OR2L3; OR4E2; OR10G2; OR11H7; OR10AD1; OR52B6; OR2D3; OR52N2; OR56B2P; OR52N4; OR56B1; OR52K1; OR52I1; OR1L8; OR9A4; OR2T34; OR2L8; OR2AJ1; OR2T10; OR2T11; OR2T3; OR10AC1; OR2L2; OR52N5; OR52P1P; OR52I2; OR1F12; OR5K1; OR5K2; OR5B12; OR5B2; OR1F2P; OR2AG1; OR10A5; OR10A2; OR10A4; OR2D2; OR51M1; OR1A1; OR51B4;	GO:0050911~detection of chemical stimulus involved in sensory perception of smell	60	435	13.7931034482759	0.00441400542122816	0.874752015536334	1	1	1	1	1
down	EREG; MPZL2; FGF1; KRT18; CPM; CASR; MNX1; EFNB2; TPD52; CST6; KRT35; MRPL40; PHLDA3; LYVE1; SOX17; SOX15; FOXQ1; FOXD4L3; SOX21; FOXD4L4; FOXC1; FOXD4L5; SOX2; FOXS1; FOXA3; SRY; SOX7; FOXD4; FOXA1; FOXI2; PITX1; SOX18;	GO:0009653~anatomical structure morphogenesis	32	127	25.1968503937008	0.00456479739680216	0.459675097857977	1	1	0.999999999998597	0.999999999998597	1
down	HTR3E; DLGAP1; KCNK3; UNC13B; GIPC1; GRM6; CACNA1G; HCRTR2; GALR3; SNCG; HTR3B; DRD5; CBLN1; SLC6A2; SLC6A1; GRIA1; SLC1A3; SLC1A1; HTR3A; OMP; NPTX2; SLC1A6; HAP1; FGF12; GRIN2A; GRIK2; PMCHL1; GRIK4; SYPL1; SYT10; PMCHL2; LPAR3; PCDHB10; PCDHB5; PCDHB4; PCDHB11; GABRA4; GABRB3; GABRQ; GABRE; DLG1; HTR4; GABRB2; CHRNA7; CHRM2; PENK; HTR1F; GABRA2; GABRG3; DLG2; GABRA3; GABRA5; HTR1D; GABRD;	GO:0007268~chemical synaptic transmission	54	249	21.6867469879518	0.00505118847997488	0.485171747285808	1	1	0.999999999998597	0.999999999998597	1
down	FZD9; PSMD11; PSMD12; PSMD14; FGF10; PSMD10; SCEL; EGFR; JUP; PSMA1; PSMA3; PSMA4; PSMA5; PSMB6; PSMB5; PSMC2; YAP1; PSMD8; DLX5; WNT3A; PSMC6; BAMBI; SEMA5A; KANK1; RSPO1; NRARP; PSMB7; PSMD1; LGR4; RSPO3; GSKIP; DKK2; WNK2; ZBED2; LYPD6;	GO:0090263~positive regulation of canonical Wnt signaling pathway	35	144	24.3055555555556	0.0050588911087398	0.485171747285808	1	1	0.999999999998597	0.999999999998597	1
up	IFNB1; IFNG; RET; LIF; IFNA21; IFNW1; IFNA5;	GO:0033141~positive regulation of peptidyl-serine phosphorylation of STAT protein	7	19	36.8421052631579	0.00521490116105572	0.880948476317877	1	1	1	1	1
down	COBL; HRAS; FAM98A; EPS8L1; P2RY12; EPS8L2; EPS8L3; EPS8;	GO:1900029~positive regulation of ruffle assembly	8	15	53.3333333333333	0.00524543143879008	0.487583026971841	1	1	0.999999999998597	0.999999999998597	1
up	HBD; HBG1; HBG2; HBA1; HBM; CYGB;	GO:0015671~oxygen transport	6	14	42.8571428571429	0.00537940085803623	0.880948476317877	1	1	1	1	1
down	ERBB2; NTF3; ERBB3; BDKRB2; TEK; CNKSR1; NRTN; BLNK; FRK; YES1; KDR; NTF4; EPHA6; FLT4; EGFR; EPHA10; PTK6; FGFR3; SRMS; CLNK; EPHA3; EPHB3; TYRO3; EPHA2; MST1R; EPHA5; EPHA1; PDGFRA; ROR1; EFS;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	30	120	25	0.00644866709496905	0.548772487152155	1	1	0.999999999998597	0.999999999998597	1
down	PTGES; EDN1; MIF; EDN2; PLA2G4A; PTGIS; PLA2G4F; MGST1;	GO:0001516~prostaglandin biosynthetic process	8	16	50	0.00701420265787722	0.550545284182526	1	1	0.999999999998597	0.999999999998597	1
down	EDN1; ADRA2A; EDN3; EDN2; BDKRB2; AGTR1; ATP1A2; ACE2;	GO:0019229~regulation of vasoconstriction	8	16	50	0.00701420265787722	0.550545284182526	1	1	0.999999999998597	0.999999999998597	1
down	SYT7; DOC2B; RIMS2; RIMS1; SYT8; SYT10; RIMS4; SYT12;	GO:0048791~calcium ion-regulated exocytosis of neurotransmitter	8	16	50	0.00701420265787722	0.550545284182526	1	1	0.999999999998597	0.999999999998597	1
down	ALOX15B; FABP5; PTGIS; LMO3; CITED2; STARD10;	GO:0035360~positive regulation of peroxisome proliferator activated receptor signaling pathway	6	9	66.6666666666667	0.0071163551032174	0.550545284182526	1	1	0.999999999998597	0.999999999998597	1
down	EDN1; EDN3; EDN2; HRC; AVPR1A; SLC1A1; NMU; RGS4; HEY2;	GO:0010460~positive regulation of heart rate	9	20	45	0.0073025416948399	0.550545284182526	1	1	0.999999999998597	0.999999999998597	1
down	UGT1A9; UGT1A1; UGT1A7; UGT1A10; UGT1A8;	GO:0051552~flavone metabolic process	5	6	83.3333333333333	0.00747181617063342	0.550545284182526	1	1	0.999999999998597	0.999999999998597	1
down	TCF21; ID1; FOXF1; STRA6; ERRFI1;	GO:0060426~lung vasculature development	5	6	83.3333333333333	0.00747181617063342	0.550545284182526	1	1	0.999999999998597	0.999999999998597	1
down	GJB6; GJB2; MIP; GJB4; GJA3;	GO:1990349~gap junction-mediated intercellular transport	5	6	83.3333333333333	0.00747181617063342	0.550545284182526	1	1	0.999999999998597	0.999999999998597	1
up	TYROBP; IFNG; APP; THBS1; AZU1; TNFRSF8; CCR2;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	7	21	33.3333333333333	0.00806808503894929	0.880948476317877	1	1	1	1	1
down	PLD2; PLA2G10; APOA4; LIPF; PLA2G2A; SULT2A1; PLD1; PLCH1; LIPK; LIPM; PLCXD3; LIPI; ASPG; PLCZ1; PLCD3; LIPH; PLA2G2F; PLA2G3; PLA1A; LPL; PNLIPRP3; LIPG;	GO:0016042~lipid catabolic process	22	81	27.1604938271605	0.00835146837341827	0.59364202249639	1	1	0.999999999998597	0.999999999998597	1
down	KPNA7; CLDN5; PDCD5; PLSCR1; RAMP2; RAMP3; NOS1AP; ALOX12B; DKK1; AGR2; IL1A; APOB; MYCN; IGF1; REG1A; CDK1; HSPA1B; BMP2; EZR; ALOX12; BMP7; DRD1; ERBB3; MAPK3; CD34; CALCR; HOXD3; CDH5; ID1; CASR; WNT5A; PTGFR; YAP1; GCGR; AFDN; WNT3A; ACTC1; LCN2; HMGN5; ANK2; POU3F1; SRY; CNTN1; PKP1; TMED2; ANGPT1; NR0B2; OCLN; IL34; SLC26A9; CAMK2N1; RIMS1; CLDN19; FAM98A; SEC16B; SMO; CITED2; OVOL2; TRIM6; MYLK2; EPB41L4B; TRPV4; DLL4; TREM2; HEY2; RIMS2; LAMP3; PKP3; IL1F10; IL36A; LGALS9C; IL36G; IL36B; LGALS9B;	GO:0010628~positive regulation of gene expression	74	374	19.7860962566845	0.00846453553196813	0.594682833536645	1	1	0.999999999998597	0.999999999998597	1
down	GABRB2; GABRG3; GABRA5; GABRA4; GABRA3; GABRA2; GABRE;	GO:0051932~synaptic transmission, GABAergic	7	13	53.8461538461538	0.00856832495784321	0.595055395348146	1	1	0.999999999998597	0.999999999998597	1
up	TYROBP; CTLA4; IL10; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	6	16	37.5	0.0089260022016977	0.880948476317877	1	1	1	1	1
down	NFIB; LRAT; TF; CYP2E1; LPL; BMP2; FABP4; PRLR; FCGR2B; NOS2; ADH7; DEFB1; SLC10A2; BNIP3; FER1L6; NAALADL2; GKN2; HERC6; MT1M; STOX2; ADAMTS9; BAIAP2L1; BAIAP2; DGKB;	GO:0009617~response to bacterium	24	92	26.0869565217391	0.00908696507167883	0.603571220757742	1	1	0.999999999998597	0.999999999998597	1
down	ALOX15B; PLA2G10; APOB; LPL; PLA2G2A; AGTR1; PLA2G5; IL18;	GO:0010744~positive regulation of macrophage derived foam cell differentiation	8	17	47.0588235294118	0.00919790315640212	0.603571220757742	1	1	0.999999999998597	0.999999999998597	1
down	CLDN5; EREG; CHP2; CLDN7; EGFR; HRAS; VIP; KRT6A; CXCL10; S100B; IGF1; SLC25A5; FGF1; EDN1; CCK; ADRA2A; NMB; TDGF1; EDN3; PDGFRA; EPCAM; XBP1; ADCYAP1; NTF3; EDN2; PTN; EPHA1; FGF7; BMP5; FGFR3; EDNRB; CNTFR; SERPINB3; ALDH3A1; CCKBR; TTK; FLT4; KDR; CHRNA7; AVPR1A; GDNF; CEACAM6; MYCNOS; THPO; CASR; AKR1C3; PTGFR; ID4; EFNB2; AKR1C2; CRIP2; EMP2; CAV3; WNT3A; RAB25; CX3CL1; HMGN5; BNC1; MST1R; DLG1; BAMBI; TBX2; KLF5; HES1; CCL14; HES5; EPGN; IL34; NCCRP1; KLB; DYNAP; FAM98A; BRK1; TFAP2B; TSLP; LGMN; S100A13; WWTR1; GAREM1; ARNT2; FGF20; ACER3; MCTS1; MAB21L2; HILPDA; TNFRSF11A; REG1A; ERBB2; ERBB3; HBEGF; TGFA; BTC; PROK1;	GO:0008284~positive regulation of cell population proliferation	93	490	18.9795918367347	0.00926847879308568	0.603571220757742	1	1	0.999999999998597	0.999999999998597	1
down	CYP1A1; CYP2C9; CYP2C19; CYP2J2; CYP4F2; CYP4A11; CYP2E1; CYP2F1; CYP2C18;	GO:0019373~epoxygenase P450 pathway	9	21	42.8571428571429	0.00929032167005461	0.603571220757742	1	1	0.999999999998597	0.999999999998597	1
down	PLA2G10; PLA2G2A; PLA2G5; PLA2G4A; PLA2G4E; PLA1A; PLA2G4F; PLA2G4D; PLA2G2F;	GO:0036150~phosphatidylserine acyl-chain remodeling	9	21	42.8571428571429	0.00929032167005461	0.603571220757742	1	1	0.999999999998597	0.999999999998597	1
up	FN1; INHBA; MMP8; MMP14; HMGA2; COL7A1; LAMB3; LAMA3;	GO:0035987~endodermal cell differentiation	8	28	28.5714285714286	0.0100016643233619	0.880948476317877	1	1	1	1	1
down	OTC; EGFR; REG1A; WNT5A; FOXF1; SMO;	GO:0007494~midgut development	6	10	60	0.0101914317041677	0.634810622232796	1	1	0.999999999998597	0.999999999998597	1
down	CYP1A1; CYP2C9; CYP2C19; CYP4F2; CYP4A11; CYP4A22;	GO:0097267~omega-hydroxylase P450 pathway	6	10	60	0.0101914317041677	0.634810622232796	1	1	0.999999999998597	0.999999999998597	1
up	SIX1; PROX1; SIX4;	GO:0030910~olfactory placode formation	3	3	100	0.0103669445108709	0.880948476317877	1	1	1	1	1
up	VIL1; CD44; PDPN;	GO:2000392~regulation of lamellipodium morphogenesis	3	3	100	0.0103669445108709	0.880948476317877	1	1	1	1	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0103669445108709	0.880948476317877	1	1	1	1	1
down	RAMP2; DDAH1; SASH1; IL1A; HSPB1; FGF1; ANXA3; C6; F3; JUP; XBP1; EPHA1; CMA1; CD34; AQP1; CDH5; APLNR; KDR; CHRNA7; WNT5A; GATA4; CCL11; HK2; CX3CL1; TEK; HYAL1; SEMA5A; ECM1; PTGIS; ANGPTL4; SMOC2;	GO:0045766~positive regulation of angiogenesis	31	131	23.6641221374046	0.0108312776456546	0.656869581465592	1	1	0.999999999998597	0.999999999998597	1
up	F2; F9; F11; GP1BA; GP9; GP5;	GO:0007597~blood coagulation, intrinsic pathway	6	17	35.2941176470588	0.0112146688317982	0.880948476317877	1	1	1	1	1
down	EDN1; EDN3; EDN2; EDNRB;	GO:0014826~vein smooth muscle contraction	4	4	100	0.011427697998845	0.656869581465592	1	1	0.999999999998597	0.999999999998597	1
down	ANXA8; PLA2R1; ANXA1; ANXA8L1;	GO:1900138~negative regulation of phospholipase A2 activity	4	4	100	0.011427697998845	0.656869581465592	1	1	0.999999999998597	0.999999999998597	1
down	MRPL3; MRPS22; MRPS10; MRPS35; MRPS11; MRPS15; MRPL51; MRPL14; MRPL21; MRPL50; GFM1; MRPL45; MRPL13; MRPL18; MRPL47; MRPL40; MRPS18A; MRPL22; MRPL35; MRPL27; MRPS33; MRPS7; MRPS18C;	GO:0070125~mitochondrial translational elongation	23	89	25.8426966292135	0.0114624134880159	0.656869581465592	1	1	0.999999999998597	0.999999999998597	1
down	PTGES; CXCL13; S100A8; GJA1; CCL11;	GO:0002544~chronic inflammatory response	5	7	71.4285714285714	0.0114974098456284	0.656869581465592	1	1	0.999999999998597	0.999999999998597	1
down	KRT18; KRT16; KRT3; KRT6C; FAM83H; EVPLL; PPL; DSP; EVPL;	GO:0045104~intermediate filament cytoskeleton organization	9	22	40.9090909090909	0.0116607550018527	0.656869581465592	1	1	0.999999999998597	0.999999999998597	1
down	GSTA4; GSTA1; GSTA2; GSTP1; GSTT2B; MGST1; GSTA3; MGST2; GSTO2;	GO:1901687~glutathione derivative biosynthetic process	9	22	40.9090909090909	0.0116607550018527	0.656869581465592	1	1	0.999999999998597	0.999999999998597	1
down	CCL21; NRG2; EREG; FGF10; RAMP3; EGFR; TGFA; ERBB2; FGF1; TXN; F3; PDGFRA; FGF7; ERBB3; FGFR3; IGFBP5; CALCR; BTC; THPO; AKR1C3; AKR1C2; CX3CL1; TEK; MST1R; C1QBP; SEMA5A; IL18; ANGPT1; FAM110C; TNFAIP8L3; EPGN; KLB; HBEGF; CCL19; P2RY12; FGF20; NOX4;	GO:0051897~positive regulation of protein kinase B signaling	37	165	22.4242424242424	0.0116927814149261	0.656869581465592	1	1	0.999999999998597	0.999999999998597	1
down	PTGES; GSTA1; HPGD; AKR1C3; AKR1C2; PTGR1; PLAA; AKR1C1;	GO:0006693~prostaglandin metabolic process	8	18	44.4444444444444	0.0118501794736428	0.656869581465592	1	1	0.999999999998597	0.999999999998597	1
down	ALOX12B; GSTA1; GSTP1; ALOX12; CYP2J2; ELOVL1; ALOXE3; ALOX15B;	GO:0043651~linoleic acid metabolic process	8	18	44.4444444444444	0.0118501794736428	0.656869581465592	1	1	0.999999999998597	0.999999999998597	1
up	ITGB4; LAMB3; LAMC2; LAMA3; COL17A1;	GO:0031581~hemidesmosome assembly	5	12	41.6666666666667	0.0119647283478423	0.880948476317877	1	1	1	1	1
down	PSMD14; CLDN7; CLDN1; PENK; HMGCR; S100A8; CYP2E1; CDK1; GSTP1; HPGD; NQO1; ADCYAP1; NPPC; CCND1; MAOB; ADH7; ADCYAP1R1; HTR3A; RGS4; OXCT1; CLDN18; ACTC1; GRIN2A; SETD7; KCNC2;	GO:0045471~response to ethanol	25	100	25	0.0120758235807021	0.659416621004077	1	1	0.999999999998597	0.999999999998597	1
up	COL6A6; SUSD5; NUAK1; FN1; APP; GP1BA; THBS1; CCL2; GP9; CD44; ITGB4; ITGB6; KITLG; CDH3; LAMA1; L1CAM; THBS2; GP5; CXCR3; CDH11; IL2; SRPX; TNFAIP6; EFNB1; COL4A3; COL7A1; COL16A1; SPOCK1; SLAMF1; MSLN; LAMC2; COL4A6; ADGRE1; FAT1; MYBPC3; COL19A1; POSTN; PTPRK; KIRREL2; FEZ1; NTM; SIRPG; CD300A; CLEC4A; CTNND2; LOXL2; NINJ2; SIGLEC5; SIGLEC12; PCDHAC1; SIGLEC10; SIGLEC14; PCDHGC5; SPON1; SIGLEC7; ICAM3; ICAM5; SIGLECL1; NINJ1;	GO:0007155~cell adhesion	59	454	12.9955947136564	0.0135644934495026	0.880948476317877	1	1	1	1	1
down	EREG; FGF10; SRPX2; RAMP2; TSPAN12; HRG; FGF1; ANXA2; CEACAM1; XBP1; EFNA1; EPHA1; S100A7; HOXA7; APLNR; SOX18; KDR; COL15A1; ID1; MEOX2; EPHB3; PROK1; YWHAZ; TEK; FOXC1; KLF5; IL18; SHB; ECM1; ECSCR; RASIP1; EPGN; CXCL17; UNC5B; PLCD3; ROBO4; HOXB13; NOX5; OVOL2; NAA15; ANGPTL4; RHOJ; SOX17; DLL4; TMEM100; HIF3A; AMOTL2; RAMP3;	GO:0001525~angiogenesis	48	230	20.8695652173913	0.0138032871811333	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	IRF6; EREG; KLK8; FST; KRT2; SDR16C5;	GO:0043616~keratinocyte proliferation	6	11	54.5454545454545	0.0141028583428398	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	CTNND1; EFNB2; YWHAE; EPS8; CPT1C; DLG3;	GO:0099072~regulation of postsynaptic membrane neurotransmitter receptor levels	6	11	54.5454545454545	0.0141028583428398	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	CLDN4; RAMP2; PSG1; PSG2; SCGB1A1; IDO1; HPGD; IGFBP2; ADRA2B; ADCYAP1; ADRA2C; ENDOU; CRHBP; IGFBP5; HSD11B2; PSG9; PSG4; PSG6; PSG7; TEAD3; SLC38A3; PSG11;	GO:0007565~female pregnancy	22	86	25.5813953488372	0.0144527793755236	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	SPTLC1; ALOX12B; PSAPL1; SPNS2; ACER1; ALOXE3; TECR; ARV1;	GO:0006665~sphingolipid metabolic process	8	19	42.1052631578947	0.01502409822812	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	PLA2G10; PLA2G2A; PLA2G5; PLA2G4A; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F;	GO:0036149~phosphatidylinositol acyl-chain remodeling	8	19	42.1052631578947	0.01502409822812	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	UGT1A9; ZMPSTE24; APOA1; HMGCR; CYP1A1; FABP1; ALAS1; NR1D1; HNF4A; ME1; HMGCS2; HMGCS1; CYP4A11; SULT2A1; TNFAIP8L3; ANGPTL8; ACER1; NPAS2; C1QTNF2; ANGPTL4; GRHL1; PPARG; PSAPL1;	GO:0019216~regulation of lipid metabolic process	23	92	25	0.015577949075712	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	SOCS2; FGF10; RAMP2; PENK; CRYAB; APOB; GSTP1; HPGD; NQO1; GJA1; IGFBP2; BMP7; PTN; CCND1; GJB2; SLC6A1; ADCYAP1R1; PTGFR; FOXA1; IHH; RBBP8; ARNT2; WFDC1; ANXA1; GGT5;	GO:0032355~response to estradiol	25	103	24.2718446601942	0.0160908245628966	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	GOT1; PCK1; MDH2; NIT2; MDH1;	GO:0006107~oxaloacetate metabolic process	5	8	62.5	0.0167778433900234	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	LIPF; FH; MDH2; ME1; MDH1;	GO:0006108~malate metabolic process	5	8	62.5	0.0167778433900234	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	GJB6; GJB1; GJA1; GJB2; GJD3;	GO:0016264~gap junction assembly	5	8	62.5	0.0167778433900234	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	DKK1; C1QA; C1QB; C1QC; CX3CL1;	GO:0098883~synapse pruning	5	8	62.5	0.0167778433900234	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
up	TLR9; TLR8; TLR7;	GO:0045356~positive regulation of interferon-alpha biosynthetic process	3	4	75	0.0169909695591718	0.880948476317877	1	1	1	1	1
up	RET; FUT7; ARTN;	GO:0097021~lymphocyte migration into lymphoid organs	3	4	75	0.0169909695591718	0.880948476317877	1	1	1	1	1
down	E2F8; POLR3G; CYP1A1; IGF1; CDK1; PAX1; IL12A; IL12B; THPO; YAP1; EMP2; DLX5; WNT3A; OCA2; PRDX1; FOXC1; IL18; KANK1; FAM83B; GRHL2; DUX4L9; FAM83A; OGFOD1; RHBDF1; CITED2; GNL3; SDCBP2; FAM83D; PAK1IP1; PAK5; LIPG; TACC2;	GO:0008283~cell population proliferation	32	142	22.5352112676056	0.0170225816244705	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
up	CCDC151; CFAP100; CFAP206; DNAAF1; WDR66; DNAH5; CCDC114; DNAI2; WDR78;	GO:0003341~cilium movement	9	38	23.6842105263158	0.0171776907057014	0.880948476317877	1	1	1	1	1
down	CLDN4; CLDN1; HRAS; ANXA1; ADRA2A; KANK1; OCLN; HBEGF; DUOX2;	GO:0090303~positive regulation of wound healing	9	24	37.5	0.0177124859421646	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
up	FN1; APP; SERPINE1; THBS1; CD44; ITGB4; ITGB6; COL8A2; LAMA1; ITGA3; LOX; ICAM3; COL4A4; MFAP2; HSPG2; COL4A3; COL7A1; COL16A1; LAMB3; LAMC2; COL4A6; COL19A1; LAMA3; PXDN; ICAM5; NR2E1; COL17A1; COL22A1; MMP10; MMP8; MMP14; MMP17; POSTN;	GO:0030198~extracellular matrix organization	33	230	14.3478260869565	0.0181200334232772	0.880948476317877	1	1	1	1	1
down	PLA2G10; APOA1; APOE; APOC3; APOB; APOA4; LPL; FABP4; XBP1; NR1D1; CD24; HNF4A; CAV3; AKR1C1; MALL; IL18; MALRD1; GPIHBP1; LIPG; NR1H4; CYP39A1;	GO:0042632~cholesterol homeostasis	21	83	25.3012048192771	0.0182144111817004	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	GLI2; HOXB1; HOXD10; HOXD3; HOXC8; MSX2; HNF1B; EMX2; ARC; SMO; CTNNBIP1; HOXC5; HES4; TDGF1; HOXA6; HOXB6; HOXD9; HOXA7; HES1; HOXC9; HOXD4; HEY2; HES2; HES5;	GO:0009952~anterior/posterior pattern specification	24	99	24.2424242424242	0.0182805410540429	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	NFASC; MAL; UGT8; EPB41L3;	GO:0002175~protein localization to paranode region of axon	4	5	80	0.0185439297541333	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	APOE; EDN1; MIF; EDNRB;	GO:0032269~negative regulation of cellular protein metabolic process	4	5	80	0.0185439297541333	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.0185439297541333	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	HPGD; FOXF1; TFAP2B; STRA6;	GO:0097070~ductus arteriosus closure	4	5	80	0.0185439297541333	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	GJB5; GJB1; GJA1; GJB2;	GO:1905867~epididymis development	4	5	80	0.0185439297541333	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	ARF4; WNT5A; SEMA3F; ABHD17C; IL1RAPL1; LRFN2; CHMP2B; DGKB;	GO:0099175~regulation of postsynapse organization	8	20	40	0.0187711178360939	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	APOE; ATP1B1; EDN3; DRD5; CCL1; KEL; CDH5; CHRNA7; CASR; CXCL12; CSRP3; CCL11; STC1; ANK2; GRIK2; RGN; CCL14; CCL13; CCL19; TRPV4; TMEM165; STOML2; ATP13A4;	GO:0006874~cellular calcium ion homeostasis	23	94	24.468085106383	0.0189157310077217	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	SULT1C4; SULT1A3; ADH7; ALDH3B2; SULT1E1; SULT2A1;	GO:0006068~ethanol catabolic process	6	12	50	0.0189485292765696	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	APOA1; APOE; APOC1; APOC3; APOA4; ABCA12;	GO:0033700~phospholipid efflux	6	12	50	0.0189485292765696	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	RAMP2; CEACAM1; CD34; KDR; TMEM100; ASB4;	GO:2001214~positive regulation of vasculogenesis	6	12	50	0.0189485292765696	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
up	IRGM; ACOD1; SERPINE1; CSF3; TFPI; CCL2; IL10; CCR5; IRF8; IL24; CEBPE; LILRB2; LILRB1; NLRP7; AICDA; PPARGC1A; DEFA4; PF4; PDCD1LG2; PF4V1; CD80; NR1I2; DEFA3; CD180; PPBP;	GO:0071222~cellular response to lipopolysaccharide	25	163	15.3374233128834	0.0191087511223967	0.880948476317877	1	1	1	1	1
down	ALOX15B; ALOX12B; HPGD; ALOX12; PON1; ALOXE3; PLA2G3;	GO:0019372~lipoxygenase pathway	7	16	43.75	0.0193376453624367	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	EDN1; EDN3; EDN2; KEL; EDNRB; HTR1D; BDKRB2;	GO:0042310~vasoconstriction	7	16	43.75	0.0193376453624367	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
up	IL27; IL21; TLR9; TLR8; TLR7;	GO:0045078~positive regulation of interferon-gamma biosynthetic process	5	14	35.7142857142857	0.0194731163776081	0.880948476317877	1	1	1	1	1
down	MRPL3; MRPS22; MRPS10; MRPS35; MRPS11; MRPS15; MRPL51; MRPL14; MRPL21; MRPL50; MRPL45; MRPL13; MRPL18; MRPL47; MRPL40; MRPS18A; MRPL22; MRPL35; MRPL27; MRPS33; MRPS7; MRPS18C;	GO:0070126~mitochondrial translational termination	22	89	24.7191011235955	0.0195413272242433	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
up	IGHD; ORM1; ORM2; PANX3;	GO:0050716~positive regulation of interleukin-1 secretion	4	9	44.4444444444444	0.0206259212212985	0.880948476317877	1	1	1	1	1
up	TYROBP; IFNG; APP; AZU1;	GO:0050725~positive regulation of interleukin-1 beta biosynthetic process	4	9	44.4444444444444	0.0206259212212985	0.880948476317877	1	1	1	1	1
up	IRGM; PPBP; ELANE; IL10; IRF8; CEBPE; LYG2; AICDA; TLR9; IGHV6-1; IGLC3; IGHV1-46; IGHV3-13; IGHV1-24; TRBC1; TRBC2; IGLC2; IGLL5; IGHV2-5; IGHD; IGHV3-49; IGHV1-18; IGHV4-34; IGHV5-51; IGHV3-35; IGHV4-31; TRDC; IGHV3-38; IGKC; IGHV3-11; IGHV3-16;	GO:0042742~defense response to bacterium	31	216	14.3518518518519	0.0213630661959371	0.880948476317877	1	1	1	1	1
down	CYP2C9; NOS1; CYP2C19; NUDT15; CYP2W1; CYP2F1; CYP2J2; CYP2C18; CYP2E1;	GO:0042738~exogenous drug catabolic process	9	25	36	0.0214730366980357	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	FMO2; CYP2F1; CYP2J2; CYP2C19; CYP2W1; CYP2E1; CYP2C9; CYP2C18;	GO:0006082~organic acid metabolic process	8	21	38.0952380952381	0.0231400992232084	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	RAB11A; RAB1A; DCTN2; MLPH; ARL6; RAB17; RAB27B; MREG;	GO:0032402~melanosome transport	8	21	38.0952380952381	0.0231400992232084	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
up	IFNG; APP; AZU1; IL13; AIF1; TLR8; TLR7;	GO:0001774~microglial cell activation	7	27	25.9259259259259	0.0233535033061473	0.880948476317877	1	1	1	1	1
down	SFN; KRT2; KDF1; EXPH5; PALLD;	GO:0003334~keratinocyte development	5	9	55.5555555555556	0.0234477216918292	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	IDO1; HAAO; TDO2; IDO2; AADAT;	GO:0006569~tryptophan catabolic process	5	9	55.5555555555556	0.0234477216918292	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	PLA2G4A; CYP2J2; CYP4F2; PTGIS; CYP4F22;	GO:0006690~icosanoid metabolic process	5	9	55.5555555555556	0.0234477216918292	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	APOA1; APOE; APOC1; APOA4; AGTR1;	GO:0010873~positive regulation of cholesterol esterification	5	9	55.5555555555556	0.0234477216918292	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	SULT1C2; SULT1C4; SULT1A3; SULT1E1; SULT2A1;	GO:0051923~sulfation	5	9	55.5555555555556	0.0234477216918292	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	CACNA1G; SLC1A6; CAV3; DLG1; GRIK3; RIMS4; POPDC3; RIMS2; GABRA3; GABRB2; RIMS1; GABRA4; GABRG3; HTR3E; GABRD; GABRA5; HTR3B; CHRNA7; GABRQ; GABRA2; HTR3A; GABRB3; PIEZO2; GABRE;	GO:0042391~regulation of membrane potential	24	102	23.5294117647059	0.0239667008172568	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
up	APOA2; ELANE; TLR8; TLR7; TLR9;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	5	15	33.3333333333333	0.024171021550769	0.880948476317877	1	1	1	1	1
down	KRT6A; KRT16; SERPINB5; RIPK4; CA9; FRAS1; TBX5;	GO:0002009~morphogenesis of an epithelium	7	17	41.1764705882353	0.0244120041232108	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	APOA1; APOE; APOC1; APOC3; APOA4; PLTP; LIPG;	GO:0034375~high-density lipoprotein particle remodeling	7	17	41.1764705882353	0.0244120041232108	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	RAP2A; EZR; WNT5A; TCF15; FOXF1; SYNE4; CAMSAP3;	GO:0045198~establishment of epithelial cell apical/basal polarity	7	17	41.1764705882353	0.0244120041232108	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
up	CD3D; KIT; IL2; SOX4; TCIRG1; RUNX2; TBX21; CD3G;	GO:0030217~T cell differentiation	8	34	23.5294117647059	0.0247057119598197	0.880948476317877	1	1	1	1	1
down	NQO1; NOS1; NOS2; SPR; SLC7A2; ARG2;	GO:0006809~nitric oxide biosynthetic process	6	13	46.1538461538462	0.0248157607881982	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	CLDN5; RAMP2; DDAH1; SLIT2; CEACAM1; ANGPT1;	GO:0043116~negative regulation of vascular permeability	6	13	46.1538461538462	0.0248157607881982	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	E2F8; CYP1A1; HNF1B; HNF4A; PCK1; ANXA1;	GO:0070365~hepatocyte differentiation	6	13	46.1538461538462	0.0248157607881982	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
up	LOX; LOXL2; LOXL4;	GO:0018057~peptidyl-lysine oxidation	3	5	60	0.0254688863996082	0.880948476317877	1	1	1	1	1
up	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.0254688863996082	0.880948476317877	1	1	1	1	1
up	HMGB3; INHBA; SFRP1;	GO:0045578~negative regulation of B cell differentiation	3	5	60	0.0254688863996082	0.880948476317877	1	1	1	1	1
down	PLA2G10; PLA2G2A; PLA2G5; PLA2G4A; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F; PLA2G3;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	9	26	34.6153846153846	0.0257734904937326	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	AHCY; MAT1A; BHMT; BHMT2;	GO:0000096~sulfur amino acid metabolic process	4	6	66.6666666666667	0.0278783051054996	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	APOE; APOC1; APOB; VLDLR;	GO:0034447~very-low-density lipoprotein particle clearance	4	6	66.6666666666667	0.0278783051054996	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	PLD2; SYT7; RAB5A; WNT3A;	GO:0036465~synaptic vesicle recycling	4	6	66.6666666666667	0.0278783051054996	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	ALOX15B; ALOX12B; ALOX12; ALOXE3;	GO:0051122~hepoxilin biosynthetic process	4	6	66.6666666666667	0.0278783051054996	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	JUP; DSP; DSC2; CTNNA3;	GO:0086073~bundle of His cell-Purkinje myocyte adhesion involved in cell communication	4	6	66.6666666666667	0.0278783051054996	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	CCL21; CD5L; ANXA1; S100A8; S100A9; KRT16; BMP2; MIF; DPEP1; SELE; SDC1; CRHBP; EPHA2; BDKRB2; FCGR2B; XCR1; BDKRB1; CSRP3; CARD18; ELF3; S100A12; MS4A2; HYAL1; IL18; IL17A; ECM1; IL34; TRIL; NLRP10; BLNK; IL17F; NR1H4; MGLL; CCL19; RARRES2; IL1RL2; CYP4F11; PLGRKT; NOX4; ACER3; STAB1; PLAA; PTGER3; CCL11; IL36A; ACKR1; CCL1; PTGFR; CXCL1; CXCL13; CCL16; CCL17; PTGER1; CCL14; GPR33; AGTR1; CXCL9; IL36G; IL1A; IL36RN; CCL13; CCL22; CCL18; IL1F10; IL1RN; IL36B; CX3CL1; CXCL11; GGT5; CCL20; CXCL10;	GO:0006954~inflammatory response	71	381	18.6351706036745	0.0278940678889589	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
up	LILRA5; IFNG; ORM1; ORM2; MMP8; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	6	22	27.2727272727273	0.0289781484688624	0.880948476317877	1	1	1	1	1
down	PGC; KLK7; KLK5;	GO:0002803~positive regulation of antibacterial peptide production	3	3	100	0.0294918273353444	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	ZMPSTE24; PPP1R13L; ADAMTS9;	GO:0003229~ventricular cardiac muscle tissue development	3	3	100	0.0294918273353444	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	CCL21; IGF1; CCL19;	GO:0010560~positive regulation of glycoprotein biosynthetic process	3	3	100	0.0294918273353444	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	FOXH1; BMP2; GATA4;	GO:0035054~embryonic heart tube anterior/posterior pattern specification	3	3	100	0.0294918273353444	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	CBR3; CYP4F2; CYP4F11;	GO:0042376~phylloquinone catabolic process	3	3	100	0.0294918273353444	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	EDN1; BMP2; CD34;	GO:0042482~positive regulation of odontogenesis	3	3	100	0.0294918273353444	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	AGXT; GPT; GPT2;	GO:0042853~L-alanine catabolic process	3	3	100	0.0294918273353444	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	TGM1; TGM3; HRNR;	GO:0043163~cell envelope organization	3	3	100	0.0294918273353444	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	PLEKHA7; KIFC3; CAMSAP3;	GO:0045218~zonula adherens maintenance	3	3	100	0.0294918273353444	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	ANXA2; SFTPD; RAB9A;	GO:0052405~negative regulation by host of symbiont molecular function	3	3	100	0.0294918273353444	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	FGF10; FGF7; TMEM38B;	GO:0061033~secretion by lung epithelial cell involved in lung growth	3	3	100	0.0294918273353444	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	HES1; HES5; LGR4;	GO:0072282~metanephric nephron tubule morphogenesis	3	3	100	0.0294918273353444	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
up	PSMB11; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-40; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGHV1-46; IGHV3-11; IGHV3-13; IGHV2-5; IGKC; IGLV7-43; IGKV1-16; IGKV3-11; IGKV4-1; IGHV4-34; IGLC2; IGLC3; MAPK10; LILRA4; PSMA8;	GO:0038095~Fc-epsilon receptor signaling pathway	25	171	14.6198830409357	0.0301230914639568	0.880948476317877	1	1	1	1	1
down	SLCO2B1; SLC22A6; SLCO2A1; SLCO4A1; SLCO1C1; SLCO6A1; SLCO5A1;	GO:0043252~sodium-independent organic anion transport	7	18	38.8888888888889	0.0303285989436622	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	DSP; DES; KRT9; KRT20; KRT2; KRT17; TCHH;	GO:0045109~intermediate filament organization	7	18	38.8888888888889	0.0303285989436622	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	FGF10; TCF21; PDGFRA; HNF1B; FOXF1; IHH; OVOL2;	GO:0048557~embryonic digestive tract morphogenesis	7	18	38.8888888888889	0.0303285989436622	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	BMP7; BMP5; CSRP3; TBX2; SGCG; GATA4; SGCD;	GO:0048738~cardiac muscle tissue development	7	18	38.8888888888889	0.0303285989436622	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	CXCL10; CCL1; S100A7; CXCL12; CXCL17; LGMN; S100A14;	GO:0090026~positive regulation of monocyte chemotaxis	7	18	38.8888888888889	0.0303285989436622	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	TEAD1; YAP1; YWHAE; TJP1; TEAD4; WWC1; TEAD3; WWTR1; AMOTL2;	GO:0035329~hippo signaling	9	27	33.3333333333333	0.0306484939590734	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
up	F2; PRL; IL5; KIT; IL10; IFNL1; IL26;	GO:0046427~positive regulation of receptor signaling pathway via JAK-STAT	7	29	24.1379310344828	0.0312177046585361	0.880948476317877	1	1	1	1	1
down	CCL22; CXCL11; DEFB4A; CCL16; PIK3C2G; CXCL14; HRAS; CXCL10; HRG; CXCL1; RALA; CCL1; CXCL12; CCL11; CCL18; DEFB1; CX3CL1; CCL20; CXCL9; PLD1; ENPP2; ECSCR; CCL17; CCL13; RARRES2; PLGRKT; XCR1;	GO:0006935~chemotaxis	27	122	22.1311475409836	0.0315074277095728	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	APOA1; APOE; APOC3; APOB; APOA4;	GO:0034378~chylomicron assembly	5	10	50	0.0316134049861645	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	EZR; DLG1; SGCD; SEH1L; MIOS;	GO:0034629~cellular protein-containing complex localization	5	10	50	0.0316134049861645	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	PSCA; PATE4; LYNX1; SLURP1; LYPD6;	GO:0099601~regulation of neurotransmitter receptor activity	5	10	50	0.0316134049861645	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	HRG; DCN; IL12A; IL12B; XDH;	GO:1900747~negative regulation of vascular endothelial growth factor signaling pathway	5	10	50	0.0316134049861645	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	APOE; FABP1; FABP4; PPARG; MFSD2A; SLC27A6;	GO:0015909~long-chain fatty acid transport	6	14	42.8571428571429	0.0317789475725915	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	IGF1; GSTP1; CX3CL1; FFAR4; TREM2; ERRFI1;	GO:0032691~negative regulation of interleukin-1 beta production	6	14	42.8571428571429	0.0317789475725915	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	TMED10; TMED2; CTAGE4; CTAGE1; CTAGE8; CTAGE3P;	GO:0035459~vesicle cargo loading	6	14	42.8571428571429	0.0317789475725915	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	SAA1; EDN2; EDNRB; SFTPD; CX3CL1; CXCL17;	GO:0048246~macrophage chemotaxis	6	14	42.8571428571429	0.0317789475725915	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	FOXP2; ITGA8; DLG1; IHH; SMO; STRA6;	GO:0048745~smooth muscle tissue development	6	14	42.8571428571429	0.0317789475725915	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	SCNN1A; SCNN1B; SCNN1G; CYP4F2; CYP4A11; TFAP2B;	GO:0055078~sodium ion homeostasis	6	14	42.8571428571429	0.0317789475725915	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	CLCA1; KCNK3; KCNK2; PGK1; S100B; EDN1; FABP1; CCNB1; BMP7; PTN; AK4; AQP1; PCK1; CASR; STC1; NPEPPS; BNIP3; PMAIP1; PTGIS; VASN; AQP3; FAM162A; ERO1A; COX4I2; HILPDA;	GO:0071456~cellular response to hypoxia	25	111	22.5225225225225	0.0320407135122379	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
up	VIL1; LMOD3; LMOD2; SCIN;	GO:0045010~actin nucleation	4	11	36.3636363636364	0.0343137268957693	0.880948476317877	1	1	1	1	1
up	INHBA; ITGB4; ITGA3; HMGA2;	GO:0048333~mesodermal cell differentiation	4	11	36.3636363636364	0.0343137268957693	0.880948476317877	1	1	1	1	1
up	GPR31; ELANE; TGFB2; IFNL1;	GO:0050778~positive regulation of immune response	4	11	36.3636363636364	0.0343137268957693	0.880948476317877	1	1	1	1	1
up	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.0358028380349784	0.880948476317877	1	1	1	1	1
up	APOA2; IL10; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	3	6	50	0.0358028380349784	0.880948476317877	1	1	1	1	1
up	SERPINE1; SERPINE2; THBS1;	GO:0010757~negative regulation of plasminogen activation	3	6	50	0.0358028380349784	0.880948476317877	1	1	1	1	1
up	PF4; SPI1; IL10;	GO:0045347~negative regulation of MHC class II biosynthetic process	3	6	50	0.0358028380349784	0.880948476317877	1	1	1	1	1
up	SERPINE1; FAM20C; HTRA1;	GO:0097187~dentinogenesis	3	6	50	0.0358028380349784	0.880948476317877	1	1	1	1	1
up	IFNG; CCL2; CCR2;	GO:1904783~positive regulation of NMDA glutamate receptor activity	3	6	50	0.0358028380349784	0.880948476317877	1	1	1	1	1
down	EML1; NFIB; KCNK3; PHGDH; NDUFS4; CTNND1; UNC5C; GNAI3; ARF4; AK4; GABRA5; ID1; SLC6A11; NES; RGS4; RIDA; ITGA8; HAP1; OXCT1; HMGCS1; GRIN2A; HES5; CNTN4; MFSD2A; CTTNBP2; FOXJ1; SLC38A3; ARL6; ARNT2; ROBO2; PCDH18; TBC1D23; CDH22; SHROOM4; BOK; BAIAP2; NDRG4; GRHL2; EMX2; SCTR; VCX; ADGRL3; ADGRL2;	GO:0007420~brain development	43	217	19.815668202765	0.0360248209589662	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	EREG; TGFA; IL1A; IGF1; EDN1; EDN3; BTC; EPGN; DMRT1;	GO:0045840~positive regulation of mitotic nuclear division	9	28	32.1428571428571	0.036129684015301	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	DLX3; DLX5; DLG1; CDX1; DLG2; DLG3; LRRC1;	GO:0009790~embryo development	7	19	36.8421052631579	0.0371364376957406	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	EPHA2; WNT5A; WNT3A; TCF15; TMED2; RIPPLY2; SP5;	GO:0036342~post-anal tail morphogenesis	7	19	36.8421052631579	0.0371364376957406	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	APOC1; APOC3; APOL4; APOL5; NPC1L1; APOA4; APOA1;	GO:0042157~lipoprotein metabolic process	7	19	36.8421052631579	0.0371364376957406	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	KCNU1; KCNK1; ABCC9; KCNK2; ATP1B1; AQP1; SLC1A3; ATP1A2; ATP1B3; KCNJ8; LRRC26; LRRC55; KCNB2; CCDC51; KCNC2; P2RY12; KCNN2; TMEM38B; KCNIP1; KCNS3; KCNK15; SLC9A4; KCNK5; KCNK7; SLC9A2; KCNV1; KCNK3;	GO:0071805~potassium ion transmembrane transport	27	125	21.6	0.0393328462680874	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
up	PF4; IL10; CXCR5; CNR2; PPBP; PF4V1;	GO:0030595~leukocyte chemotaxis	6	24	25	0.0394738435541259	0.880948476317877	1	1	1	1	1
down	NFASC; ANK2; UGT8; EPB41L3;	GO:0030913~paranodal junction assembly	4	7	57.1428571428571	0.0395391559254011	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	SLC22A3; POMC; SCTR; HTR4;	GO:0032098~regulation of appetite	4	7	57.1428571428571	0.0395391559254011	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	IDO1; NOS1; ADCYAP1R1; LRP11;	GO:0033555~multicellular organismal response to stress	4	7	57.1428571428571	0.0395391559254011	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	S100A8; SERPINB3; CX3CL1; HILPDA;	GO:0035425~autocrine signaling	4	7	57.1428571428571	0.0395391559254011	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	AK4; AK2; AK3; AMPD1;	GO:0046033~AMP metabolic process	4	7	57.1428571428571	0.0395391559254011	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	CD1C; CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	4	7	57.1428571428571	0.0395391559254011	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	FGF10; WNT7B; FOXJ1; ERRFI1;	GO:0060428~lung epithelium development	4	7	57.1428571428571	0.0395391559254011	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	FGF10; SPRY1; YAP1; RDH10;	GO:0060449~bud elongation involved in lung branching	4	7	57.1428571428571	0.0395391559254011	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	YAP1; FOXA1; GRHL2; TMEM38B;	GO:0060487~lung epithelial cell differentiation	4	7	57.1428571428571	0.0395391559254011	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	IL33; CX3CL1; IL34; TREM2;	GO:0061518~microglial cell proliferation	4	7	57.1428571428571	0.0395391559254011	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	AQP1; RHCG; RHBG; RHCE;	GO:0072488~ammonium transmembrane transport	4	7	57.1428571428571	0.0395391559254011	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	ANXA8; SPINK6; SPINK5; ANXA8L1;	GO:1900004~negative regulation of serine-type endopeptidase activity	4	7	57.1428571428571	0.0395391559254011	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	ATP1B1; ATP1B3; WNK4; WNK2;	GO:1903288~positive regulation of potassium ion import across plasma membrane	4	7	57.1428571428571	0.0395391559254011	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	PENK; CCK; GJA1; NPAS2;	GO:2000987~positive regulation of behavioral fear response	4	7	57.1428571428571	0.0395391559254011	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	GGCT; GGT5; GGT6; CHAC2; MGST2; CHAC1;	GO:0006750~glutathione biosynthetic process	6	15	40	0.0398978091484308	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	GABRA2; ICA1; SLC6A15; SLC6A14; GABRQ; SLC18A1;	GO:0006836~neurotransmitter transport	6	15	40	0.0398978091484308	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	MUC2; MUC13; STRAP; TFF3; TFF2; TFF1;	GO:0030277~maintenance of gastrointestinal epithelium	6	15	40	0.0398978091484308	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	KRT14; KRT16; KRT33B; MPZL3; PPP1R13L; KRTAP4-8;	GO:0042633~hair cycle	6	15	40	0.0398978091484308	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	PLA2G4D; ABHD12; GDPD3; PLA2G4A; PLA2G4F; PLA2G4E;	GO:0046475~glycerophospholipid catabolic process	6	15	40	0.0398978091484308	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	PGR; TACSTD2; EDNRB; SERPINB5; HES1; HES5;	GO:0050678~regulation of epithelial cell proliferation	6	15	40	0.0398978091484308	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	EFNA1; BMP5; FOXA1; PPP2CA; VASN; TBX5; OVOL2; STRAP;	GO:0010719~negative regulation of epithelial to mesenchymal transition	8	24	33.3333333333333	0.040409689202937	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
up	CCL24; FGF18; TSHB; GHRH; WNT1; INHBA; PTHLH; GATA1; TRH; SSTR3; VIPR2; FASLG; CCR5; IL2; CCL7; CRB1; TNFAIP6; EFNB1; GRAP; FAT1; LILRB2; FCRL2; IL26; SIRPG; TRHDE; CCL26; PANX3; DRD2; ADRA1D; FGFBP2; DRD3;	GO:0007267~cell-cell signaling	31	230	13.4782608695652	0.0412733914695609	0.880948476317877	1	1	1	1	1
down	FUT1; FUT3; FUT2; FUT9; FUT6;	GO:0036065~fucosylation	5	11	45.4545454545455	0.041350665568899	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	APOE; ACHE; NSG1; DLG1; KLK6;	GO:0042982~amyloid precursor protein metabolic process	5	11	45.4545454545455	0.041350665568899	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	DSP; IHH; PLEKHA7; KIFC3; CAMSAP3;	GO:0090136~epithelial cell-cell adhesion	5	11	45.4545454545455	0.041350665568899	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	JUP; DSP; DSC2; DLG1; CTNNA3;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	5	11	45.4545454545455	0.041350665568899	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	WNT5A; AFDN; FOXA1; WNT3A; TJP1;	GO:2000049~positive regulation of cell-cell adhesion mediated by cadherin	5	11	45.4545454545455	0.041350665568899	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
up	IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-40; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGHV1-46; IGHV3-11; IGHV3-13; IGHV2-5; IGKC; IGLV7-43; IGKV1-16; IGKV3-11; IGKV4-1; IGHV4-34; IGLC2; IGLC3; HBA1; HSPG2;	GO:0006898~receptor-mediated endocytosis	23	160	14.375	0.0418972779719332	0.880948476317877	1	1	1	1	1
down	FGF10; SPRY1; BMP7; GDNF; ITGA8; IRX3; RDH10; SOX17; ROBO2;	GO:0001656~metanephros development	9	29	31.0344827586207	0.0422452006345897	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	CXCL11; CXCL10; DRD1; APLNR; BDKRB1; CX3CL1; CXCL9; NPSR1; F2RL3;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	9	29	31.0344827586207	0.0422452006345897	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
up	CCDC151; DNAAF1; DNAH5; CCDC114; DNAI2;	GO:0036158~outer dynein arm assembly	5	18	27.7777777777778	0.0423768081071425	0.880948476317877	1	1	1	1	1
down	GPR37; FGF10; ALOX12B; HRAS; IGF1; ADRA2A; BMP2; ADRB3; ADRA2B; ADRA2C; EFNA1; FGFR3; ADRA1A; FLT4; KDR; THPO; SOX2; CAV2; CX3CL1; KISS1; WWC1; ROR1; TEK; ERBB2;	GO:0043410~positive regulation of MAPK cascade	24	109	22.0183486238532	0.0424591494700618	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
up	THBS1; IL10; SLAMF1; TIGIT;	GO:0032695~negative regulation of interleukin-12 production	4	12	33.3333333333333	0.0427257373242514	0.880948476317877	1	1	1	1	1
up	CD44; COL8A2; ICAM3; FAT1; COL19A1; KIRREL2; NLGN2; FBLIM1; NRCAM; PKP2; ROPN1B; TENM2; ICAM5; DSG4; CDH11; LAMA3; CTNND2; CDH13; CDH3; COL16A1; CDH26; ICOS;	GO:0098609~cell-cell adhesion	22	152	14.4736842105263	0.0433129329311603	0.880948476317877	1	1	1	1	1
down	MYO1B; SORBS2; TF; TMSB15A; CCL11; EMP2; CAV3; CGNL1; DLG1; PDLIM3; BRK1; POF1B; RND1; TRPV4; SHROOM4; SHROOM3; MYO5B; MYO6; RND3; RHOJ; LMOD1; RHOV; RHOD; ACTC1; MYO5C; MYO1A;	GO:0007015~actin filament organization	26	121	21.4876033057851	0.0444638980562932	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	CXCL13; EDN1; NMB; SAA1; PDGFRA; GJA1; ADCYAP1; EDN2; CCL1; EDNRB; CD24; BDKRB2; AGTR1; CCKBR; ADRA1A; AVPR1A; BDKRB1; NMU; CAV3; FFAR4; PLCZ1; SPPL3; TRPV4; LPAR3; PTGER3; GPR33; KISS1; PTGER1; XCR1; PTGFR; CALCR;	GO:0007204~positive regulation of cytosolic calcium ion concentration	31	150	20.6666666666667	0.0448120598956495	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	SYNGR3; CRHBP; TMED10; RAB10; ABCA12; RIMS1; TMEM79;	GO:0045055~regulated exocytosis	7	20	35	0.044875756509302	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	NOS1AP; ZMPSTE24; CACNA2D1; CAV3; ANK2; SCN5A; KCNE4;	GO:0060307~regulation of ventricular cardiac muscle cell membrane repolarization	7	20	35	0.044875756509302	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	CCL21; CLDN7; TF; EPCAM; DUOXA2; CCL19; DUOX2;	GO:2000147~positive regulation of cell motility	7	20	35	0.044875756509302	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
up	CALCA; GPR18; DRD2; GPR65; P2RY10; DRD3; GPR174; GPR55;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	8	39	20.5128205128205	0.0451412247155382	0.880948476317877	1	1	1	1	1
down	RBP1; ALDH1A3; RDH10;	GO:0002138~retinoic acid biosynthetic process	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	C2CD4B; C2CD4A; CTNNBIP1;	GO:0002528~regulation of vascular permeability involved in acute inflammatory response	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	FGF10; WNT7B; FRAS1;	GO:0003338~metanephros morphogenesis	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	CYP2E1; EDN1; SCGB1A1;	GO:0010193~response to ozone	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	SPDEF; SOSTDC1; NKX6-2;	GO:0010454~negative regulation of cell fate commitment	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	S100A8; NOS1; NOS2;	GO:0018119~peptidyl-cysteine S-nitrosylation	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	GLI2; TRNP1; SMO;	GO:0021696~cerebellar cortex morphogenesis	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	S100A8; S100A9; SLC30A8;	GO:0032119~sequestering of zinc ion	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	ADRA2A; ADRA2B; ADRA2C;	GO:0032811~negative regulation of epinephrine secretion	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	CIDEA; APOA4; LY6D;	GO:0035634~response to stilbenoid	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	IL12A; IL12B; IL18;	GO:0035744~T-helper 1 cell cytokine production	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	EZR; DLG1; TRPV4;	GO:0043622~cortical microtubule organization	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	SPINT1; NKX6-1; NKX6-2;	GO:0045687~positive regulation of glial cell differentiation	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	FKBP4; DMRT3; DMRT1;	GO:0046661~male sex differentiation	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	PLD2; PLD1; TNFAIP8L3;	GO:0048017~inositol lipid-mediated signaling	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	SOX18; OVOL2; SOX17;	GO:0060214~endocardium formation	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	AKR1C3; AKR1C2; AKR1C1;	GO:0071395~cellular response to jasmonic acid stimulus	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	TEK; HES1; ANGPT1;	GO:0072012~glomerulus vasculature development	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	DKK1; WNT5A; MESP1;	GO:0090082~positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	DLG1; DLG2; DLG3;	GO:0099562~maintenance of postsynaptic density structure	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	PTN; CHRNA7; ZNF365;	GO:0140059~dendrite arborization	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	MCIDAS; CCNO; DEUP1;	GO:1903251~multi-ciliated epithelial cell differentiation	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	TJP1; ANGPT1; OCLN;	GO:1905605~positive regulation of maintenance of permeability of blood-brain barrier	3	4	75	0.0468545027482399	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	PSMD11; PSMD12; PSMD14; WNT9B; FZD7; PSMD10; PSMA1; PSMA3; PSMA4; PSMA5; PSMB6; PSMB5; PSMC2; WNT5A; PSMD8; PSMC6; ROR1; PSMB7; PSMD1; FZD4;	GO:0060071~Wnt signaling pathway, planar cell polarity pathway	20	88	22.7272727272727	0.0476447786101544	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	IL20RB; IL1A; IL36A; IL1RN; IL36RN; IL1F10; IL36G; IL36B;	GO:0002437~inflammatory response to antigenic stimulus	8	25	32	0.0476727942464212	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	PAH; GOT1; GPT; PYCR1; ASPA; ASPG; GPT2; FOLH1B;	GO:0008652~cellular amino acid biosynthetic process	8	25	32	0.0476727942464212	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	CTSV; CTSB; GJA1; PTN; MAPK3; GJB2; STC1; PTGIS;	GO:0046697~decidualization	8	25	32	0.0476727942464212	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
up	SLC38A5; SLC32A1; SLC6A20;	GO:0015816~glycine transport	3	7	42.8571428571429	0.0479492726032805	0.880948476317877	1	1	1	1	1
up	GATA2; SATB2; TBR1;	GO:0021902~commitment of neuronal cell to specific neuron type in forebrain	3	7	42.8571428571429	0.0479492726032805	0.880948476317877	1	1	1	1	1
up	BPI; IL10; TLR9;	GO:0032717~negative regulation of interleukin-8 production	3	7	42.8571428571429	0.0479492726032805	0.880948476317877	1	1	1	1	1
up	TGFB2; SIX1; SIX4;	GO:0048699~generation of neurons	3	7	42.8571428571429	0.0479492726032805	0.880948476317877	1	1	1	1	1
up	APOA2; SCT; APOA5;	GO:0050996~positive regulation of lipid catabolic process	3	7	42.8571428571429	0.0479492726032805	0.880948476317877	1	1	1	1	1
up	TMOD1; LMOD3; LMOD2;	GO:0051694~pointed-end actin filament capping	3	7	42.8571428571429	0.0479492726032805	0.880948476317877	1	1	1	1	1
down	RALA; HAP1; LGI3; RAPGEF4; RIMS2; PCLO; RAB10; RAB3C; RAB13;	GO:0017157~regulation of exocytosis	9	30	30	0.0490192624647321	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	NPR3; IGFBP5; IL12A; IL12B; PPARG; CTNNBIP1; NDRG4; NDRG2; VIP;	GO:0048662~negative regulation of smooth muscle cell proliferation	9	30	30	0.0490192624647321	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	FGF10; APOA1; TF; IGF1; SULT1A3; MAPK3; KDR; CCL11; YWHAZ;	GO:0070371~ERK1 and ERK2 cascade	9	30	30	0.0490192624647321	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	APOA1; XBP1; CD34; TEK; DLG1; NOX5;	GO:0001935~endothelial cell proliferation	6	16	37.5	0.0492162210703651	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	RAB25; IHH; DACT2; GRHL2; POF1B; PALLD;	GO:0003382~epithelial cell morphogenesis	6	16	37.5	0.0492162210703651	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
down	GRID2; SSTR1; GRIN2A; GRIK2; GRIK3; GRIK4;	GO:0007215~glutamate receptor signaling pathway	6	16	37.5	0.0492162210703651	0.680363425448068	1	1	0.999999999998597	0.999999999998597	1
